Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease

Acta Biomaterialia

Volumn 25, Issue , 2015, Pages 172-183

  Yin, Tiantian ^a   Yang, Licong ^a   Liu, Yanan ^a   Zhou, Xianbo ^a   Sun, Jing ^a   Liu, Jie ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

B6 peptide; Blood brain barrier; Fibril; Oligomer; Selenium nanoparticles

Indexed keywords

ATOMIC EMISSION SPECTROSCOPY; BLOOD; BRAIN; CAPILLARY ELECTROPHORESIS; CARBOXYLIC ACIDS; CYTOLOGY; DIAGNOSIS; ENDOTHELIAL CELLS; ENZYME ACTIVITY; INDUCTIVELY COUPLED PLASMA; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NEURODEGENERATIVE DISEASES; PEPTIDES; SELENIUM; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

ALZHEIMERS DISEASE; B6 PEPTIDE; BLOOD-BRAIN BARRIER; BRAIN DISEASE; FIBRIL; HOMOEOSTASIS; MICROENVIRONMENTS; PC12 CELLS; SELENIUM NANOPARTICLES; SIALIC ACIDS;

OLIGOMERS;

AMYLOID BETA PROTEIN[1-40]; B6 PEPTIDE; NANOPARTICLE; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; SELENIUM NANOPARTICLE; SIALIC ACID; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; BIOMATERIAL; N ACETYLNEURAMINIC ACID; OLIGOPEPTIDE; PEPTIDE; PROTEIN AGGREGATE; SELENIUM;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL SURVIVAL; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; PARTICLE SIZE; PC12 CELL LINE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SPECTROPHOTOMETER; ZETA POTENTIAL; ANIMAL; CELL PROTECTION; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; METABOLISM; MOUSE; PATHOLOGY; PERMEABILITY; RAT; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; COATED MATERIALS, BIOCOMPATIBLE; CYTOPROTECTION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICROSCOPY, CONFOCAL; N-ACETYLNEURAMINIC ACID; NANOPARTICLES; OLIGOPEPTIDES; PC12 CELLS; PEPTIDES; PERMEABILITY; PROTEIN AGGREGATES; RATS; SELENIUM;

EID: 84940826772     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.06.035     Document Type: Article

References (42)

1. H.L. Wong, N. Chattopadhyay, X.Y. Wu, and R. Bendayan Nanotechnology applications for improved delivery of antiretroviral drugs to the brain Adv. Drug Deliv. Rev. 62 2010 503 517
2. L. Biddlestone-Thorpe, N. Marchi, K. Guo, C. Ghosh, D. Janigro, K. Valerie, and et al. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents Adv. Drug Deliv. Rev. 64 2012 605 613
3. S. Krol Challenges in drug delivery to the brain: nature is against us J. Control. Release 164 2012 145 155
4. I. van Rooy, E. Mastrobattista, G. Storm, W.E. Hennink, and R.M. Schiffelers Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain J. Control. Release 150 2011 30 36
5. G.A. Silva, Nanotechnology applications and approaches for neuroregeneration and drug delivery to the central nervous system, in: R.J. Andrews, W. Slikker, B. Trembly, T.A. Patterson (eds.), Neuroprotective Agents, 221-230, 2010.
6. M. Zhang, X.B. Mao, Y. Yu, C.X. Wang, Y.L. Yang, and C. Wang Nanomaterials for reducing amyloid cytotoxicity Adv. Mater. 25 2013 3780 3801
7. M.C. Branco, and J.P. Schneider Self-assembling materials for therapeutic delivery Acta Biomater. 5 2009 817 831
8. Z.Y. Liu, M.Y. Jiang, T. Kang, D.Y. Miao, G.Z. Gu, Q.X. Song, and et al. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration Biomaterials 34 2013 3870 3881
9. R. Prades, S. Guerrero, E. Araya, C. Molina, E. Salas, E. Zurita, and et al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor Biomaterials 33 2012 7194 7205
10. Y. Nie, D. Schaffert, W. Rodl, M. Ogris, E. Wagner, and M. Gunther Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy J. Control. Release 152 2011 127 134
11. F.I. Staquicini, M.G. Ozawa, C.A. Moya, W.H.P. Driessen, E.M. Barbu, H. Nishimori, and et al. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma J. Clin. Invest. 121 2011 161 173
12. Z.Y. Liu, X.L. Gao, T. Kang, M.Y. Jiang, D.Y. Miao, G.Z. Gu, and et al. B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide Bioconjug. Chem. 24 2013 997 1007
13. B. Wang, B. Yu, M. Karim, H.H. Hu, Y. Sun, P. McGreevy, and et al. Dietary sialic acid supplementation improves learning and memory in piglets Am. J. Clin. Nutr. 85 2007 561 569
14. D.G. Peng, J.S. Zhang, Q.L. Liu, and E.W. Taylor Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity J. Inorg. Biochem. 101 2007 1457 1463
15. J.S. Zhang, X.Y. Gao, L.D. Zhang, and Y.P. Bao Biological effects of a nano red elemental selenium BioFactors 15 2001 27 38
16. X. Wang, K. Sun, Y.P. Tan, S.S. Wu, and J.S. Zhang Efficacy and safety of selenium nanoparticles administered intraperitoneally for the prevention of growth of cancer cells in the peritoneal cavity Free Radical Biol. Med. 72 2014 1 10
17. A. Smith, B. Giunta, P.C. Bickford, M. Fountain, J. Tan, and R.D. Shytle Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease Int. J. Pharm. 389 2010 207 212
18. G.V. Kryukov, S. Castellano, S.V. Novoselov, A.V. Lobanov, O. Zehtab, R. Guigo, and et al. Characterization of mammalian selenoproteomes Science 300 2003 1439 1443
19. M.P. Rayman Selenium and human health Lancet 379 2012 1256 1268
20. I.A. Siddiqui, V.M. Adhami, D.J. Bharali, B.B. Hafeez, M. Asim, S.I. Khwaja, and et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate Cancer Res. 69 2009 1712 1716
21. L.C. Yang, Q.C. Chen, Y. Liu, J.N. Zhang, D.D. Sun, Y.H. Zhou, and et al. Se/Ru nanoparticles as inhibitors of metal-induced A beta aggregation in Alzheimer's disease J. Mater. Chem. B 2 2014 1977 1987
22. J.N. Zhang, X.B. Zhou, Q.Q. Yu, L.C. Yang, D.D. Sun, Y.H. Zhou, and et al. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-beta aggregation and cytotoxicity ACS Appl. Mater. Interfaces 6 2014 8475 8487
23. J.T. Pedersen, C. Hureau, L. Hemmingsen, N.H.H. Heegaard, J. Ostergaard, M. Vasak, and et al. Rapid exchange of metal between Zn-7-metallothionein-3 and amyloid-beta peptide promotes amyloid-related structural changes Biochemistry 51 2012 1697 1706
24. M. Bartolini, C. Bertucci, V. Cavrini, and V. Andrisano Beta-amyloid aggregation induced by human acetylcholinesterase: inhibition studies Biochem. Pharmacol. 65 2003 407 416
25. G. Grelle, A. Otto, M. Lorenz, R.F. Frank, E.E. Wanker, and J. Bieschke Black tea theaflavins inhibit formation of toxic amyloid-beta and alpha-synuclein fibrils Biochemistry 50 2011 10624 10636
26. S.H. Baik, M.Y. Cha, Y.M. Hyun, H. Cho, B. Hamza, D.K. Kim, and et al. Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model Neurobiol. Aging 35 2014 1286 1292
27. Q.Q. Yu, Y.A. Liu, C. Wang, D.D. Sun, X.C. Yang, Y.Y. Liu, and et al. Chiral ruthenium(II) polypyridyl complexes: stabilization of G-quadruplex DNA, inhibition of telomerase activity and cellular uptake PLoS ONE 7 2012
28. R. Jain, N. Jordan, D. Schild, E.D. van Hullebusch, S. Weiss, C. Franzen, and et al. Adsorption of zinc by biogenic elemental selenium nanoparticles Chem. Eng. J. 260 2015 855 863
29. A. Cimini, B. D'Angelo, S. Das, R. Gentile, E. Benedetti, V. Singh, and et al. Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of A beta aggregates modulate neuronal survival pathways Acta Biomater. 8 2012 2056 2067
30. D. Liu, B.Q. Lin, W. Shao, Z. Zhu, T.H. Ji, and C.Y. Yang In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier ACS Appl. Mater. Interfaces 6 2014 2131 2136
31. D.E. Ehrnhoefer, J. Bieschke, A. Boeddrich, M. Herbst, L. Masino, R. Lurz, and et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15 2008 558 566
32. R.S. Omtri, M.W. Davidson, B. Arumugam, J.F. Poduslo, and K.K. Kandimalla Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery Mol. Pharm. 9 2012 1887 1897
33. M.Y. Cha, S.H. Han, S.M. Son, H.S. Hong, Y.J. Choi, J. Byun, and et al. Mitochondria-specific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death PLoS One 7 2012
34. P. Picone, D. Nuzzo, L. Caruana, V. Scafidi, and M. Di Carlo Mitochondrial dysfunction: different routes to Alzheimer's disease therapy Oxidative Med. Cell. Longevity 2014
35. P. Picone, R. Carrotta, G. Montana, M.R. Nobile, P.L.S. Biagio, and M. Di Carlo A beta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures Biophys. J. 96 2009 4200 4211
36. M. Das, and S.K. Sahoo Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy (Retraction of vol. 7, pg. 355, 2011) Acta Biomater. 9 2013 7076
37. Q.C. Chen, L.C. Yang, C.P. Zheng, W.J. Zheng, J.N. Zhang, Y.S. Zhou, and et al. Mo polyoxometalate nanoclusters capable of inhibiting the aggregation of A beta-peptide associated with Alzheimer's disease Nanoscale 6 2014 6886 6897
38. M. Li, X.J. Yang, J.S. Ren, K.G. Qu, and X.G. Qu Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease Adv. Mater. 24 2012 1722 1728
39. M. Li, S.E. Howson, K. Dong, N. Gao, J.S. Ren, P. Scott, and et al. Chiral metallohelical complexes enantioselectively target amyloid beta for treating Alzheimer's disease J. Am. Chem. Soc. 136 2014 11655 11663
40. X.R. Cheng, B.Y.H. Hau, A.J. Veloso, S. Martic, H.B. Kraatz, and K. Kerman Surface plasmon resonance imaging of amyloid-beta aggregation kinetics in the presence of epigallocatechin gallate and metals Anal. Chem. 85 2013 2049 2055
41. F.L. Palhano, J. Lee, N.P. Grimster, and J.W. Kelly Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils J. Am. Chem. Soc. 135 2013 7503 7510
42. T.T. Chen, X.Y. Wang, Y.F. He, C.L. Zhang, Z.Y. Wu, K. Liao, and et al. Effects of cyclen and cyclam on zinc(II)- and copper(II)-induced amyloid beta-peptide aggregation and neurotoxicity Inorg. Chem. 48 2009 5801 5809